ENHANCING ONCOLOGY ANALYSIS WITH BUILT-IN KRAS ASSAY PRODUCTS AND SERVICES AND RAS ASSAYS

from the rapidly evolving area of oncology investigation, exact and productive mutation screening is vital for creating targeted therapies. The KRAS companies Platform plays a pivotal role In this particular landscape by providing in depth solutions for KRAS mutation profiling and Examination. KRAS mutations, found in approximately ninety five% of